angiotensin ii has been researched along with fisetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Earp, HS; Huckle, WR | 1 |
| Chen, RJ; Chen, YF; Chen, YP; Day, CH; Huang, CY; Lai, CH; Peramaiyan, R; Shen, CY; Shibu, MA; Sivalingam, K; Viswanadha, VP | 1 |
2 other study(ies) available for angiotensin ii and fisetin
| Article | Year |
|---|---|
Synergistic activation of tyrosine phosphorylation by o-vanadate plus calcium ionophore A23187 or aromatic 1,2-diols.
Topics: Acetylcysteine; Angiotensin II; Animals; Calcimycin; Cell Line; Cell Line, Transformed; Drug Synergism; Egtazic Acid; Enzyme Activation; Flavonoids; Flavonols; Indomethacin; Liver; Masoprocol; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Quercetin; Rats; Tyrosine; Vanadates | 1994 |
Protective effect of Fisetin against angiotensin II-induced apoptosis by activation of IGF-IR-PI3K-Akt signaling in H9c2 cells and spontaneous hypertension rats.
Topics: Angiotensin II; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Survival; Flavonoids; Flavonols; Hypertension; Male; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Rats, Inbred SHR; Rats, Wistar; Receptor, IGF Type 1; Receptors, Somatomedin; Signal Transduction | 2019 |